Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05VKS
|
|||
| Drug Name |
VT-122
|
|||
| Indication | Hepatocellular carcinoma [ICD-11: 2C12.02; ICD-10: C22.0; ICD-9: 155] | Phase 2 | [1], [2] | |
| Pancreatic cancer [ICD-11: 2C10] | Phase 1 | [2] | ||
| Company |
Vicus Therapeutics Morristown, NJ
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.